Lyra Therapeutics Inc (LYRA) Testing Investors’ Patience Right Now
Currently, there are 65.46M common shares owned by the public and among those 53.57M shares have been available to trade. The company’s stock has a 5-day price change of -2.51% and -20.65% over the past three months. LYRA shares are trading -7.66% year to date (YTD), with the 12-month market performance down to -96.31% lower. […]
